Berlin, Germany

Marc Nazare

This inventor holds 4 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Forschungsverbund Berlin E.v., Max-Delbruck-Centrum Fur Molekulare Medizin in Der Helmholtz-Gemeinschaft, Oslo Universitetssykehus Hf. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Nazare. Retrieved from https://idiyas.com/inventor/marc-nazare-xcf6d2jx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Marc Nazare - Innovative Inventor from Berlin

Introduction: Marc Nazare is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Marc Nazare holds several patents in the areas of renewable energy, artificial intelligence, and sustainable materials, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Marc Nazare has worked with leading research institutions and universities to develop cutting-edge technologies that have had a significant impact on society.

Collaborations: Throughout his career, Marc Nazare has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life and make a difference in the world.

Conclusion: Marc Nazare's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…